Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor

Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor

US Patent 11732049 · Granted Aug 22, 2023

Estimated economic value: $4,328,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ILT-binding agents and methods of use thereof2025
Polynucleotides encoding human beta klotho antibodies or binding fragments there2025
Polynucleotides encoding human beta klotho antibodies or binding fragments there2025
Methods of treating inflammatory diseases by blocking Galectin-32025
LAIR-1-binding agents and methods of use thereof2025
Treating cancer by blocking the interaction of TIM-3 and its ligand2025
Continuous manufacturing process for bispecific antibody products2025
Multi-target kinase inhibitor, pharmaceutical composition, and preparation metho2025
ILT3-binding agents and methods of use thereof2025
Binding proteins and methods of use thereof2024
Binding proteins and methods of use thereof2024
Binding proteins and methods of use thereof2024